The treatment goal for cerebral AVMs is mainly to prevent hemorrhage. Bleeding risks of cerebral AVMs depend on several factors such as size/location of the nidus, types of presentation, and angiographical cure does not necessarily mean no risk of hemorrhage. The treatment strategy based on Spetzler-Martin grading is proposed in several guidelines: Grade I, II, and III are a therapeutic target; Grade IV and V should be treated conservatively. According to AHA Scientific Statement, surgical extirpation should be conceded for Spetzler-Martin Grade I and II, and surgical extirpation with preoperative feeder embolization is often effective for SpetzlerMartin Grade III, but single surgical extirpation is not recommended for Spetzler-Martin Grade IV and V. Although low grade AVMs are reported to be amenable to extirpation with low morbidity, patient selection bias seems to reduce estimates of risk.

